Adwan K,Abu-Hijleh N,Adwan A,Awwad G,E G .2014 .Molecular characterization of Escherichia coli isolates from patients with urinary tract infections in Palestine. , 63(2) : 229-234.
Ali BH,Blunden G .2003 .Pharmacological and toxicological properties of Nigella sativa. Phytother. Res., 17(4) : 299-305.
Alqannam R .2020 .Antibacterial and Alteration of drug resistance activities of black cumin seed (Nigella Sativa) extracts against urinary pathogens. J. Infect. Public Health, 13(2) : 321-322.
Anderson GG,Palermo JJ,Schilling JD,Roth R,Heuser J,Hultgren SJ .2003 .Intracellular bacterial biofilmlike pods in urinary tract infections. Science, 301(5629) : 105-107.
Aronson M,Medalia O,Schori L,Mirelman D,Sharon N,Ofek I .1979 .Prevention of colonization of the urinary tract of mice with Escherichia coli by blocking of bacterial adherence with methyl alpha-Dmannopyranoside. J. Infect. Dis., 139(3) : 329-32.
Basavegowda N,Patra JK,Baek KH .2020 .Essential oils and mono/bi/tri-metallic nanocomposites as alternative sources of antimicrobial agents to combat multidrug-resistant pathogenic microorganisms: an overview. Molecules, 25(5) : 1058.
Bauernfeind A,Holley M,Jungwirth R,Mangold P,Röhnisch T,Schweighart S,Wilhelm R,Casellas JM,Goldberg M JM .1992 .A new plasmidic cefotaximase from patients infected with Salmonella typhimurium. Infection, 20(3) : 158-163.
Begum S,Nizami SS,Mahmood U,Masood S,Iftikhar S,Saied S S .2018 .In-vitro evaluation and in-silico studies applied on newly synthesized amide derivatives of N-phthaloylglycine as butyrylcholinesterase (BChE) inhibitors. Comput. Biol. Chem, 74 : 212-217.
Bjelkmar P,Larsson P,Cuendet MA,Hess B,Lindahl E .2010 .Implementation of the CHARMM Force Field in GROMACS: Analysis of protein stability effects from correction maps, virtual interaction sites, and water models. J. Chem. Theory Comput., 6(2) : 459-466.
Boskabadi M and Shirmohammadi B .2002 .Effect of Nigella sativa on isolated guinea pig trachea. Archives Iranian Medicine, 5 : 103-107.
Coque Cantón R,TM Cantón R .2006 .The CTX-M betalactamase pandemic. Curr. Opin. Microbiol., 9, (5) : 466-75.
Castro RI,Valenzuela-Riffo F,Morales-Quintana L,- L .2019 .-triyl) tris (azanediyl)) triphenol), an antioxidant agent with a possible antiinflammatory function. Biomed. Res. Int., doi: 10, (4) : 5.
Chaieb K,Kouidh B,Jrah H,Mahdouani K,Bakhrouf A .2011 .Antibacterial activity of thymoquinone, an active principle of Nigella sativa and its potency to prevent bacterial biofilm formation. BMC Complement. Altern. Med, 11(1) : 29.
Chen SL,Hung CS,Pinkner JS,Walker JN,Cusumano CK,Li Z,Bouckaert J,Gordon JI,Hultgren SJ .2009 .Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding. Proc. Natl. Acad. Sci., 106(52) : 22439-22444.
Dhanasekaran S .2019 .Research article alteration of multi-drug resistance activities by ethanolic extracts of Nigella sativa against urinary pathogens. Int. J. Pharmacol., 15 : 962-969.
Domenici L,Monti M,Bracchi C,Giorgini M,Colagiovanni V,Muzii L,Benedetti panici P. .2016 .D-mannose: A promising support for acute urinary tract infections in women. A pilot study. Eur. Rev. Med, 20(13) : 2920-2925.
Drawz SM,Bonomo R A .2010 .Three decades of beta-lactamase inhibitors. Clin. Microbiol, 23(1) : 160-201.
Duguid JP,Gillies RR,Pathol RR .1957 .Fimbrias and Adhesive Properties in Dysentery Bacilli. , 74(2) : 397-411.
Ehmann DE,Jahić H,Ross PL,Gu R,Hu J,Kern G,Walkup GK,Fisher SL .2012 .Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor. Proc. Natl. Acad. Sci., 109(29) : 11663-11668.
El-ariny E,Amer A,El-senosy Y,Naaom S Y .2020 .Antimicrobial activity of Nigella Sativa and Lawsonia inermis (Henna) against Gram negative bacteria isolated from clinical samples. j. biotechnol. biochem, 6(3) : 32-37.
Eltai NO,Al Thani AA,Al-Ansari K,Deshmukh AS,Wehedy E,Al-Hadidi SH,Yassine HM .2018 .Molecular characterization of extended spectrum β - lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population. Antimicrob, 7(1) : 90.
Faheem M,Rehman MT,Danishuddin M,Khan AU M .2013 .Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel nonβ-lactam-β-lactamase inhibitor. PLoS One, 8(2) : e56926.
Fam N,Leflon-Guibout V,Fouad S,Aboul-Fadl L,Marcon E,Desouky D,El-Defrawy I,Abou-Aitta A,Klena J,Nicolas-Chanoine MH .2011 .CTX-M15-producing Escherichia coli clinical isolates in Cairo (Egypt), including isolates of clonal complex ST10 and clones ST131, ST73 and ST405 in both community and hospital settings. Microb. Drug. Resist., 17(1) : 67-73.
Forouzanfar F,Bazzaz BSF,Hosseinzadeh H BSF .2014 .Black cumin (Nigella sativa) and its constituent (thymoquinone): a review on antimicrobial effects. Iran J. Basic Med. Sci, 17(12) : 929-938.
Foxman B .2010 .The epidemiology of urinary tract infection. Nat. Rev. Urol., 7(12) : 653-660.
Genovese C,Davinelli S,Mangano K,Tempera G,Nicolosi D,Corsello S,Vergalito F,Tartaglia E,Scapagnini G,Di Marco R G .2018 .Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. J. Chemother., 30(2) : 107-114.
Gonzalez CM,SChaeffer AJ CM .1999 .Treatment of urinary tract infection: what's old, what's new, and what works. World J. Urol., 17(6) : 372-82.
Hammadi A,Abed H,Rabie ZH H .2020 .Effect extraction of nigella sativa and malricaia chamoilla on urinary tract infection. Sci. J. Med. Res., 4(16) : 118-124.
Harrington RD,Hooton TM .2000 .Urinary tract infection risk factors and gender. J. Gend. Specif. Med, 3(8) : 27-34.
Hartmann M and Lindhorst TK .2011 .The bacterial lectin FimH, a target for drug discovery-carbohydrate inhibitors of type 1 fimbriae‐mediated bacterial adhesion. European J. Org. Chem, : 3583-3609.
Hayatdavoud P,Rad AK,Rajaei Z,Hadjzadeh MAR .2016 .Renal injury, nephrolithiasis and Nigella sativa: A mini review. Avicenna J. Phytomed., 6(1) : 1-8.
Hess B,Kutzner C,Van Der Spoel D and Lindahl E .2008 .GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation. J. Chem. Theory. Comput., 4(3) : 435-447.
Hung CS,Bouckaert J,Hung D,Pinkner J,Widberg C,DeFusco A,Auguste CG,Strouse R,Langermann S,Waksman G,Hultgren SJ .2002 .Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol. Microbiol, 44(4) : 903-15.
Hussain A,Ewers C,Nandanwar N,Guenther S,Jadhav S,Wieler LH,Ahmed N LH .2012 .Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: Genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-β- lactamase-producing lineage. Antimicrob, 56(12) : 6358-65.
Kim T,Afonin KA,Viard M,Koyfman AY,Sparks S,Heldman E,Grinberg S,Linder C,Blumenthal RP,Shapiro BA .2013 .In silico, in vitro and in vivo studies indicate the potential use of bolaamphiphiles for therapeutic siRNas delivery. Molecular TherapyNucleic acids, 2 : e80.
King DT,King AM,Lal SM,Wright GD,Strynadka NC .2015 .Molecular mechanism of avibactammediated β-lactamase inhibition. ACS Infectious Diseases, 1(4) : 175-184.
Klein T,Abgottspon D,Wittwer M,Rabbani S,Herold J,Jiang X,Kleeb S,Lüthi C,Scharenberg M,Bezençon J,Gubler E .2010 .FimH antagonists for the oral treatment of urinary tract infections: From design and synthesis to in vitro and in vivo evaluation. J. Med, 53(24) : 8627-8641.
Krammer EM,De Ruyck J,Roos G,Bouckaert J,Lensink MF .2018 .Targeting dynamical binding processes in the design of non-antibiotic anti-adhesives by molecular simulation-the example of FimH. , 23(7) : 1641.
Lahiri SD,Johnstone MR,Ross PL,McLaughlin RE,Olivier NB,Alm RA .2014 .Avibactam and class C β-lactamases: Mechanism of inhibition, conservation of the binding pocket, and implications for resistance. Antimicrob, 58(1) : 5704-13.
Lahiri SD,Mangani S,Durand-Reville T,Benvenuti M,De Luca F,Sanyal G,Docquier JD .2013 .Structural insight into potent broad-spectrum inhibition with reversible recyclization mechanism: Avibactam in complex with CTX-M-15 and Pseudomonas aeruginosa AmpC β-lactamases. , 57(6) : 2496-2505.
Malik A,Jamil U,Butt TT,Waquar S,Gan SH,Shafique H,Jafar TH H .2019 .In silico and in vitro studies of lupeol and iso-orientin as potential antidiabetic agents in a rat model. Drug Des. Devel. Ther., 13 : 1501-1513.
Mandal SP,Garg A,Prabitha P,Wadhwani AD,Adhikary L,Kuma BP .2018 .Novel glitazones as PPARγ agonists: Molecular design, synthesis, glucose uptake activity and 3D QSAR studies. Chem, 12(1) : 141.
Nilsson L Mark P.,SPC Mark P.,Phys. Chem Mark P. .2001 .Structure and dynamics of the TIP3P, SPC, and. , 105(53) : 9954-9960.
Mayer K,Eris D,Schwardt O,Sager CP,Rabbani S,Kleeb S,Ernst B,Med B .2017 .Urinary Tract infection: which conformation of the bacterial lectin fimh is therapeutically relevant? J. , 60(13) : 5646-5662.
Mohammed MA,Alnour TM,Shakurfo OM,Aburass MM,Pac Libya. Asian .2016 .Prevalence and antimicrobial resistance pattern of bacterial strains isolated from patients with urinary tract infection in Messalata Central Hospital. J. Trop. Med, 9(8) : 771-776.
Mousavifar L,Touaibia M,Roy R M .2018 .Development of Mannopyranoside Therapeutics against Adherent-Invasive Escherichia coli Infections. Acc. Chem. Res., 51(11) : 2937-2948.
Mousavifar L,Vergoten G,Charron G,Roy R G .2019 .Comparative study of aryl o-, c- and s-mannopyranosides as potential adhesion inhibitors toward uropathogenic E. coli FimH. , 24(19) : 3566.
Mydock-McGrane LK,Cusumano ZT,Janetka JW .2016 .Mannose-derived FimH antagonists: A promising anti-virulence therapeutic strategy for urinary tract infections and Crohn's disease. Expert. Opin. Ther. Pat., 26(2) : 175-97.
Mydock-McGrane LK,Hannan TJ,Janetka JW .2017 .Rational design strategies for FimH antagonists: new drugs on the horizon for urinary tract infection and Crohn's disease. Expert Opin, 12(7) : 711-731.
Namjoo A,Sadri SM,Rafeian M,Ashrafi K,Shahin Fard N and Moosavi Azmareh F .2013 .Comparing the effects of Nigella Sativa extract and gentamicin in treatment of urinary tract infection caused by E. coli. J. Mazandaran Univ. Med, 22(96) : 22-29.
Ofek I,Mirelman D,Sharon N D .1977 .Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors. Nature, 265(5595) : 623-625.
Oraiopoulou ME,Tzamali E,Tzedakis G,Liapis E,Zacharakis G,Vakis A,Papamatheakis J,Sakkalis V .2018 .Integrating in vitro experiments with in silico approaches for Glioblastoma invasion: the role of cellto-cell adhesion heterogeneity. Scientific Reports, 8(1) : 1-13.
Rafsanjany N,Senker J,Brandt S,Dobrindt U,Hensel A .2015 .In vivo consumption of cranberry exerts ex vivo antiadhesive activity against fimh-dominated uropathogenic Escherichia coli: A combined in vivo, ex vivo and in vitro study of an extract from Vaccinium macrocarpon. J. Agric. Food Chem, 63(40) : 8804-8818.
Ribić R,Meštrović T,Neuberg M,Kozina G .2018 .Effective anti-adhesives of uropathogenic Escherichia coli. Acta. Pharm, 68(1) : 1-18.
Rizvi SMD,Shaikh S,Naaz D,Shakil S,Ahmad A,Haneef M,Abuzenadah AM M .2016 .Kinetics and molecular docking study of an anti-diabetic drug glimepiride as acetylcholinesterase inhibitor: implication for alzheimer's disease-diabetes dual therapy. Neurochem. Res., 41(6) : 1475-82.
Ronald A .2003 .The etiology of urinary tract infection: traditional and emerging pathogens. Dis, 49 : 71-82.
Sarshar M,Behzadi P,Ambrosi C,Zagaglia C,Palamara AT,Scribano D AT .2020 .FimH and anti-adhesive therapeutics: A disarming strategy against uropathogens. Antibiotics, 9(7) : 397.
Schwardt O,Rabbani S,Hartmann M,Abgottspon D,Wittwer M,Kleeb S,Zalewski A,Smiesko M,Cutting B,Ernst B B .2011 .Design, synthesis and biological evaluation of mannosyl triazoles as FimH antagonists. Bioorg. Med, 19(21) : 6454-6473.
Shaikh S,MD Rizvi S,Hameed N,Biswas D,Khan M,Shakil S,A Kamal M S .2014 .Aptiom (eslicarbazepine acetate) as a dual inhibitor of β- secretase and voltage-gated sodium channel: advancement in Alzheimer's disease-epilepsy linkage via an enzoinformatics study. CNS Neurol. Disord. Drug Targets, 13(7) : 1258-1262.
Shi C,Yan C,Sui Y,Sun Y,Guo D,Chen Y,Jin T,Peng X,Ma L,Xia X .2017 .Thymoquinone inhibits virulence related traits of Cronobacter sakazakii ATCC 29544 and has anti-biofilm formation potential. Front. Microbiol., : 2220.
Snyder JA,Lloyd AL,Lockatell CV,Johnson DE,Mobley HL .2006 .Role of phase variation of type 1 fimbriae in a uropathogenic Escherichia coli cystitis isolate during urinary tract infection. Infect. Immun., 74(2) : 1387-1393.
Srinivasan K .2018 .Cumin (Cuminum cyminum) and black cumin (Nigella sativa) seeds: traditional uses, chemical constituents, and nutraceutical effects. Food Quality and Safety, 2(1) : 1-16.
Stahlhut SG,Tchesnokova V,Struve C,Weissman SJ,Chattopadhyay S,Yakovenko O,Aprikian P,Sokurenko EV,Krogfelt KA .2009 .Comparative structure-function analysis of mannose-specific FimH adhesins from Klebsiella pneumoniae and Escherichia coli. J. Bacteriol., 191(21) : 6592-6601.
Tayh G,Al Laham N,Ben Yahia H,Ben Sallem R,Elottol AE,Ben Slama K AE .2019 .Extendedspectrum β-Lactamases among Enterobacteriaceae isolated from urinary tract infections in Gaza Strip, Palestine. Biomed. Res. Int, : .
Utami AT .2018 .Nigella sativa Linn. and lower urinary tract infection treatment. J Surg Pathol Diagn, 1(1) : 101.
Verma A,Rizvi SMD,Shaikh S,Ansari MA,Shakil S,Ghazal F,Siddiqui MH,Haneef M,Rehman A .2014 .Compounds isolated from Ageratum houstonianum inhibit the activity of matrix metalloproteinases (MMP-2 and MMP-9): An oncoinformatics study. Pharmacogn, 10(37) : 18-26.
Winkler ML,Papp-Wallace KM,Taracila MA,Bonomo RA .2015 .Avibactam and inhibitor-resistant SHV β-lactamases. , 59(7) : 3700-3709.
Zhou G,Mo WJ,Sebbel P,Min G,Neubert TA,Glockshuber R,Wu XR,Sun TT,Kong XP .2001 .Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: Evidence from in vitro FimH binding. J. Cell Sci, 114(22) : 4095-4103.
Zoete V,Cuendet MA,Grosdidier A,Michielin O .2011 .Swiss Param: A fast force field generation tool for small organic molecules. J Comput Chem, 32(11) : 2359-2368.
Zorgani A,Almagatef A,Sufya N,Bashein A,Tubbal A,Med A .2017 .Detection of CTX-M-15 Among uropathogenic Escherichia coli isolated from five major hospitals in Tripoli, Libya. , 32(4) : 322-327.